1
Brief Regulatory History of
Antidepressants and Suicidality
and
Update on Current Plans for
Analysis of  Pediatric Suicidality Data
from Controlled Trials
Thomas Laughren, M.D.
Team Leader, Psychiatric Drug
Products Group
Division of Neuropharmacological Drug
Products, FDA